AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
businesswire.com
ABCL
AbCellera announces a collaboration with Vertex to discover multispecific T-cell engagers for autoimmune diseases. The article does not provide details on the financial implications or performance of AbCellera.
VRTX
Vertex Pharmaceuticals is collaborating with AbCellera to discover multispecific T-cell engagers for autoimmune diseases. The article focuses on the discovery aspect and does not offer insights into Vertex's financial performance or stock outlook.